JP2023506805A5 - - Google Patents
Info
- Publication number
- JP2023506805A5 JP2023506805A5 JP2022535918A JP2022535918A JP2023506805A5 JP 2023506805 A5 JP2023506805 A5 JP 2023506805A5 JP 2022535918 A JP2022535918 A JP 2022535918A JP 2022535918 A JP2022535918 A JP 2022535918A JP 2023506805 A5 JP2023506805 A5 JP 2023506805A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- chain variable
- variable region
- amino acid
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911294912.3 | 2019-12-16 | ||
| CN201911294912 | 2019-12-16 | ||
| PCT/CN2020/136396 WO2021121204A1 (zh) | 2019-12-16 | 2020-12-15 | 抗cea抗体-依喜替康类似物偶联物及其医药用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023506805A JP2023506805A (ja) | 2023-02-20 |
| JP2023506805A5 true JP2023506805A5 (cg-RX-API-DMAC7.html) | 2023-12-20 |
| JP7827624B2 JP7827624B2 (ja) | 2026-03-10 |
Family
ID=76478217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022535918A Active JP7827624B2 (ja) | 2019-12-16 | 2020-12-15 | 抗cea抗体-エキサテカン類似体複合体及びその医薬用途 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230055408A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4079761A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7827624B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220113747A (cg-RX-API-DMAC7.html) |
| CN (2) | CN118453897A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020410460A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022011632A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3163130A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022007312A (cg-RX-API-DMAC7.html) |
| MY (1) | MY209735A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI887316B (cg-RX-API-DMAC7.html) |
| UA (1) | UA129521C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021121204A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230101735A1 (en) * | 2020-01-22 | 2023-03-30 | Jiangsu Hengrui Medicine Co., Ltd. | Anti-trop-2 antidody-exatecan analog conjugate and medical use thereof |
| JP7767613B2 (ja) | 2021-11-15 | 2025-11-11 | システィミューン,インコーポレイテッド | 二重特異性抗体-カンプトテシン薬物複合体及びその製薬的使用 |
| EP4489862A1 (en) * | 2022-03-09 | 2025-01-15 | Merck Patent GmbH | Anti-ceacam5 antibodies and conjugates and uses thereof |
| AU2024380559A1 (en) | 2023-11-17 | 2026-06-04 | Mersana Therapeutics, Inc. | Treatment of cancer using b7-h4-targeted antibody-drug conjugates |
| KR20260115642A (ko) | 2023-11-20 | 2026-07-24 | 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 | 재조합 반응을 통해 이종다량체를 제조하는 방법 |
| WO2026151884A1 (en) | 2025-01-09 | 2026-07-16 | Mersana Therapeutics, Inc. | Treatment of cancer using b7-h4-targeted antibody-drug conjugates |
| WO2026158363A1 (zh) * | 2025-01-22 | 2026-07-30 | 石药集团巨石生物制药有限公司 | 抗体-药物偶联物及其用途 |
| CN120504738B (zh) * | 2025-07-21 | 2025-10-21 | 南京滴力生物科技有限公司 | 一种抗δ样配体3的单克隆抗体及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| EP1558284B1 (en) * | 2002-10-08 | 2013-09-11 | Immunomedics, Inc. | Combination therapy with naked class iii anti-cea monoclonal antibodies and therapeutic agents |
| ES2605443T3 (es) | 2003-11-06 | 2017-03-14 | Seattle Genetics, Inc. | Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia |
| CN102850400A (zh) * | 2011-06-30 | 2013-01-02 | 周文强 | 喜树碱衍生物及其制备方法、药物组合物与用途 |
| CN104168899B (zh) | 2012-01-13 | 2017-04-05 | 通用医疗公司 | 麻醉剂化合物及其相关的使用方法 |
| US10195288B2 (en) | 2012-10-11 | 2019-02-05 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate |
| CN107753954A (zh) * | 2012-12-13 | 2018-03-06 | 免疫医疗公司 | 功效改进且毒性降低的抗体与sn‑38的免疫缀合物的剂量 |
| FR3008408B1 (fr) * | 2013-07-11 | 2018-03-09 | Mc Saf | Nouveaux conjugues anticorps-medicament et leur utilisation en therapie |
| JP6427789B2 (ja) * | 2013-07-23 | 2018-11-28 | イミューノメディクス、インコーポレイテッドImmunomedics, Inc. | Cl2aリンカーを有する抗体−sn−38免疫複合体 |
| EP3066470A4 (en) * | 2013-11-05 | 2017-05-31 | Immunomedics, Inc. | Humanized anti-ceacam5 antibody and uses thereof |
| SG11201603960XA (en) | 2014-01-31 | 2016-07-28 | Daiichi Sankyo Co Ltd | Anti-her2 antibody-drug conjugate |
| KR20190133233A (ko) * | 2017-03-30 | 2019-12-02 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 항체-약물 접합체를 제조하는 방법 |
| CA3044082A1 (en) * | 2017-04-03 | 2018-10-11 | Immunomedics, Inc. | Subcutaneous administration of antibody-drug conjugates for cancer therapy |
| TW202115125A (zh) * | 2019-06-26 | 2021-04-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 抗cea抗體及其應用 |
-
2020
- 2020-12-15 BR BR112022011632A patent/BR112022011632A2/pt unknown
- 2020-12-15 MY MYPI2022002981A patent/MY209735A/en unknown
- 2020-12-15 JP JP2022535918A patent/JP7827624B2/ja active Active
- 2020-12-15 WO PCT/CN2020/136396 patent/WO2021121204A1/zh not_active Ceased
- 2020-12-15 CN CN202410472219.5A patent/CN118453897A/zh active Pending
- 2020-12-15 US US17/785,373 patent/US20230055408A1/en active Pending
- 2020-12-15 MX MX2022007312A patent/MX2022007312A/es unknown
- 2020-12-15 CN CN202080078185.1A patent/CN114729035B/zh active Active
- 2020-12-15 EP EP20902845.5A patent/EP4079761A4/en active Pending
- 2020-12-15 UA UAA202202371A patent/UA129521C2/uk unknown
- 2020-12-15 CA CA3163130A patent/CA3163130A1/en active Pending
- 2020-12-15 KR KR1020227023180A patent/KR20220113747A/ko active Pending
- 2020-12-15 AU AU2020410460A patent/AU2020410460A1/en active Pending
- 2020-12-16 TW TW109144510A patent/TWI887316B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023510905A5 (cg-RX-API-DMAC7.html) | ||
| JP2023505708A5 (cg-RX-API-DMAC7.html) | ||
| JP2022511351A5 (cg-RX-API-DMAC7.html) | ||
| JP2023519261A5 (cg-RX-API-DMAC7.html) | ||
| TWI904149B (zh) | B7h3抗體-依喜替康類似物偶聯物及其醫藥用途 | |
| TWI796245B (zh) | 抗體-藥物結合物之用途 | |
| JP6914956B2 (ja) | 抗5t4抗体および抗体−薬物コンジュゲート | |
| EP3678700B1 (en) | Compounds for reducing the viscosity of biological formulations | |
| JP7827624B2 (ja) | 抗cea抗体-エキサテカン類似体複合体及びその医薬用途 | |
| EP3186278A1 (en) | Internalizing moieties for treatment of cancer | |
| CN116096896A (zh) | 一种含抗体药物偶联物的药物组合物及其用途 | |
| JP2024536798A5 (cg-RX-API-DMAC7.html) | ||
| RU2022125170A (ru) | Конъюгат антитела против PSMA и аналога эксатекана и его медицинское применение | |
| JP2023500385A5 (cg-RX-API-DMAC7.html) | ||
| RU2021110631A (ru) | Конъюгат лиганд-лекарственное средство аналога экзатекана, способ его получения и его применение | |
| TH2101001650A (th) | ลิแกนด์-ดรักคอนจูเกตของสารแอนะล็อกของเอกซาทีแคน, วิธีการเตรียมสำหรับคอนจูเกตนั้น และการประยุกต์ใช้คอนจูเกตดังกล่าว | |
| JP2025540696A (ja) | 抗cldn18.2抗体薬物複合体、その医薬組成物及び使用 | |
| RU2021110824A (ru) | Конъюгат антитело к b7h3-аналог экзатекана и его применение в медицине | |
| RU2025102276A (ru) | КОНЪЮГАТ АНТИТЕЛО-ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩИЙ МУТАНТНУЮ Fc-ОБЛАСТЬ | |
| RU2021135114A (ru) | Конъюгат антитела к b7-h4 и лекарственного средства и его медицинское применение | |
| WO2025232682A1 (zh) | 海兔毒素类似物及其配体偶联药物及其制备方法与应用 | |
| RU2025110275A (ru) | Лекарственное средство на основе ауристатина с высокостабильным гидрофильным линкерным элементом и его конъюгат | |
| RU2022110139A (ru) | Производное каптотецина и его конъюгат | |
| IL324844A (en) | Nectin-4 antibodies and antibody-drug conjugates | |
| RU2024116437A (ru) | Конъюгат антитело-лекарственное средство и его применение |